E Fund Management (HK)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$660K Buy
550
+443
+414% +$453K 0.22% 72
2026
Q1
$98.4K Buy
107
+76
+245% +$77K 0.04% 159
2025
Q4
$32.4K Buy
31
+24
+343% +$22.9K 0.01% 175
2025
Q3
$5.34K Buy
+7
New +$5.21K ﹤0.01% 154
2025
Q1
Sell
-136
Closed -$105K 176
2024
Q4
$105K Buy
+136
New +$113K 0.08% 50
2024
Q2
Sell
-121
Closed -$94K 136
2024
Q1
$94K Buy
+121
New +$86.1K 0.06% 53

Other funds holding LLY

E Fund Management (HK)'s LLY Position: Q2 2026 in Review

E Fund Management (HK) increased its Eli Lilly (LLY) stake by 414% in Q2 2026, buying an estimated $453K and bringing the position to 550 shares worth $660K. The position accounts for 0.22% of the portfolio, ranked #72.

E Fund Management (HK) first reported a position in LLY in Q1 2024 and has held it in 6 quarters since. 1,393 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • E Fund Management (HK) held 550 shares of Eli Lilly worth $660K as of Q2 2026.
  • E Fund Management (HK) bought 443 Eli Lilly shares in Q2 2026, an estimated $453K.
  • Eli Lilly made up 0.22% of E Fund Management (HK)'s portfolio in Q2 2026, its #72 holding.
  • E Fund Management (HK) first reported a position in Eli Lilly in Q1 2024 and has held it in 6 quarters since.
  • 1,393 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.